With many disease-causing bacteria ratcheting up their shields against current drugs, new tactics are vital to protect people from treatment-resistant infections.
Lowering mutation rates in harmful bacteria might be an as yet untried way to hinder the emergence of antimicrobial-resistant pathogens. This proposed strategy comes from recent findings in infectious disease research at UW Medicine in Seattle.
The University of Washington maintained its No. 10 spot on the U.S. News & World Report’s Best Global Universities rankings, released Tuesday. The UW is second among American public institutions. UW Microbiology is ranked #4!
Host: Dr Michelle Reniere
Host: Dr Adam Geballe
- Interspecies chemical signaling in a methane-oxidizing bacterial community.
Applied and environmental microbiology - Feb, 2019
Puri AW, Liu D, Schaefer AL, Yu Z, Pesesky MW, Greenberg EP, Lidstrom ME
- Correction: Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1.
PLoS pathogens - Feb, 2019
Mackelprang RD, Bamshad MJ, Chong JX, Hou X, Buckingham KJ, Shively K, deBruyn G, Mugo NR, Mullins JI, McElrath MJ, Baeten JM, Celum C, Emond MJ, Lingappa JR,
- The Mla system and glycerophospholipid transport to the outer membrane.
eLife - Jan, 2019
Kamischke C, Fan J, Bergeron J, Kulasekara HD, Dalebroux ZD, Burrell A, Kollman JM, Miller SI
- β-Barrel outer membrane proteins suppress mTORC2 activation and induce autophagic responses.
Science signaling - Nov, 2018
Chaudhary A, Kamischke C, Leite M, Altura MA, Kinman L, Kulasekara H, Blanc MP, Wang G, Terhorst C, Miller SI
- Relational concurrency, stages of infection, and the evolution of HIV set point viral load.
Virus evolution - Jul, 2018
Goodreau SM, Stansfield SE, Murphy JT, Peebles KC, Gottlieb GS, Abernethy NF, Herbeck JT, Mittler JE